These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
594 related items for PubMed ID: 18830757
1. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS. Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757 [Abstract] [Full Text] [Related]
2. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS. Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221 [Abstract] [Full Text] [Related]
3. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome. Kempkensteffen C, Hinz S, Schrader M, Christoph F, Magheli A, Krause H, Schostak M, Miller K, Weikert S. Cancer Lett; 2007 Sep 08; 254(2):227-35. PubMed ID: 17449173 [Abstract] [Full Text] [Related]
4. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A. Ann Surg Oncol; 2010 Mar 08; 17(3):923-32. PubMed ID: 19898900 [Abstract] [Full Text] [Related]
6. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]. Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW. Korean J Hepatol; 2008 Jun 08; 14(2):185-96. PubMed ID: 18617766 [Abstract] [Full Text] [Related]
9. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. Clin Cancer Res; 2002 Apr 08; 8(4):1087-92. PubMed ID: 11948118 [Abstract] [Full Text] [Related]
10. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y. Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857 [Abstract] [Full Text] [Related]
13. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW. Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071 [Abstract] [Full Text] [Related]
14. Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta. Micali OC, Cheung HH, Plenchette S, Hurley SL, Liston P, LaCasse EC, Korneluk RG. BMC Cancer; 2007 Mar 21; 7():52. PubMed ID: 17376236 [Abstract] [Full Text] [Related]
16. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter]. Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG. Zhonghua Zhong Liu Za Zhi; 2007 Mar 21; 29(3):166-70. PubMed ID: 17649629 [Abstract] [Full Text] [Related]
17. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Li X, Hui AM, Sun L, Hasegawa K, Torzilli G, Minagawa M, Takayama T, Makuuchi M. Clin Cancer Res; 2004 Nov 15; 10(22):7484-9. PubMed ID: 15569978 [Abstract] [Full Text] [Related]
18. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery. Lee HH, Uen YH, Tian YF, Sun CS, Sheu MJ, Kuo HT, Koay LB, Lin CY, Tzeng CC, Cheng CJ, Tang LY, Tsai SL, Wang AH. Cancer Epidemiol Biomarkers Prev; 2009 May 15; 18(5):1562-9. PubMed ID: 19423534 [Abstract] [Full Text] [Related]
19. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH. Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2260-7. PubMed ID: 18723830 [Abstract] [Full Text] [Related]
20. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y. Ann Surg Oncol; 2010 Jul 15; 17(7):1917-26. PubMed ID: 20112070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]